International Expansion of Medical Products in Asia and Europe

「また、韓国で上市した「ロイヒつぼ膏TMコインプラスター」については、販売代理店によるテレビCM等の広告媒体を活用したPR活動により、現地薬局での取り扱い店舗数が増加し、売上高は前年同期を上回りました。」

「The Roihi TsubokoTM Coin Plaster launched in South Korea during the current fiscal year contributed to higher sales. As a result, total field sales amounted to ¥2.796 billion, up 13.4% year on year.」

「高機能救急絆創膏「ケアリーヴTM」シリーズは、韓国にて「ケアリーヴTM治す力TM防水タイプ」を上市しましたが、販売代理店の在庫調整等もあり、前年同期を下回りました。一方、今期に韓国で上市した「ロイヒつぼ膏TMコインプラスター」が売上増加に寄与しました。」

「Sales of the CareleavesTM series of high-performance wound dressings fell below the same period of the previous year due to the impact of distributor inventory adjustments. Meanwhile, the new Roihi TsubokoTM Coin Plaster launched in South Korea made a significant contribution to sales. As a result, total field sales amounted to ¥1.317 billion, up 18.0% year on year.」

「Adoption of the SesabrickTM series of hemostatic products increased in China and Europe, driving growth, while sales of the CareleavesTM series significantly exceeded the same period of the previous year, mainly in South Korea and Thailand, following the completion of inventory adjustments from the previous fiscal year. In addition, the weaker yen contributed to sales, and total field sales amounted to ¥1.116 billion, up 72.6% year on year.」

「In Asia and Europe, our priority regions, we conducted locally focused sales activities with distributors centered on the CareleavesTM series of high-performance wound dressings and the SesabrickTM series of hemostatic products. Although signs of improvement are emerging for the CareleavesTM series, sales remained significantly below the same period of the previous year due to the continuing impact of inventory adjustments by distributors in the first half. As a result, total field sales amounted to ¥1.192 billion, down 7.9% year on year.」

「Sales of the CareleavesTM series fell significantly below the same period of the previous year, due to excess distributor inventories. As a result, total field sales amounted to ¥648 million, down 20.1% year on year.」

「Sales of the CareleavesTM series fell below the same period of the previous year, due to excess distributor inventories. As a result, total field sales amounted to ¥399 million, down 13.6% year on year.」

「In this environment, we conducted locally focused sales activities with distributors in Asia and Europe, our priority regions, centered on the CareleavesTM series of high-performance wound dressings and the SesabrickTM series of hemostatic products. The CareleavesTM series performed well, mainly in South Korea, as sales channels expanded, while medical materials products in ASEAN and Europe also performed steadily. In addition, the weaker yen contributed to sales, and overseas field sales for the medical business amounted to ¥1.295 billion, up 23.2% year on year.」

「In this environment, we conducted locally focused sales activities with partners in Asia and Europe, our priority regions, centered on the CareleavesTM series of high-performance wound dressings and the SesabrickTM series of hemostatic products. The CareleavesTM series performed well, mainly in South Korea, as sales channels expanded, while medical materials products in ASEAN and Europe also performed steadily. As a result, overseas field sales for the medical business exceeded the same period of the previous year.」

「The CareleavesTM series performed well, mainly in South Korea, as sales channels expanded, while medical materials products in ASEAN and Europe also performed steadily. As a result, overseas field sales for the medical business were significantly higher than in the same period of the previous year.」

「To expand the business through a three-location sales structure in Japan, Thailand, and Germany, we will rapidly strengthen our local capabilities and pursue new customer development.」

「In Asia and Europe, our priority regions, we conducted locally focused sales activities, including expanding the lineup and raising awareness of the CareleavesTM series of high-performance wound dressings, and increasing the number of facilities adopting the SesabrickTM series of hemostatic products while promoting their infection-control benefits.」

「In Asia and Europe, our priority regions, we conducted locally focused sales activities, including expanding the lineup and raising awareness of the CareleavesTM series of high-performance wound dressings, and increasing the number of facilities adopting the SesabrickTM series of hemostatic products while promoting their infection-control benefits.」

「To expand the business through a three-location sales structure in Japan, Thailand, and Germany, we will rapidly strengthen our local capabilities and roll out a new overseas business strategy.」

「Focusing on Asia and Europe, we are building sales channels and nurturing products for medical business products, including the CareleavesTM series of high-performance wound dressings and the SesabrickTM series of hemostatic products, as well as tape business products such as PanfixTM Cellulose Tape and Japanese paper masking tape for painting. To strengthen business operations and expand sales throughout Europe, we established NICHIBAN EUROPE GmbH, a sales subsidiary in Düsseldorf, Germany, during the third quarter of the current consolidated fiscal period.」

「In this environment, we advanced the rollout of AtfineTM, a tape designed specifically for caring for postoperative scars, in the Chinese market and strengthened our efforts in cross-border e-commerce sites. We are also focusing on Asia and Europe, building sales channels and nurturing products for medical business products, including the CareleavesTM series of high-performance wound dressings and the SesabrickTM series of hemostatic products, as well as tape business products such as PanfixTM Cellulose Tape and Japanese paper masking tape for painting. In addition, we are proceeding with the establishment of a sales base in Germany to strengthen business operations and expand sales throughout Europe.」

「In this environment, we began expanding AtfineTM, a tape designed specifically for caring for postoperative scars, in China.」

「We are focusing on sales activities in China, South Korea, and Taiwan in East Asia, particularly strengthening our efforts in the Chinese market through cross-border e-commerce.」

「In our overseas business, Asia and Europe are priority regions, but the outlook for the sales environment remains uncertain amid worsening relations between Japan and South Korea, a slowdown in the Chinese economy, and civil demonstrations in Hong Kong. In this environment, we are focusing on building sales channels and nurturing products for medical business products, including the high-performance wound dressing CareleavesTM and the SesabrickTM series of hemostatic products, as well as tape business products such as PanfixTM Cellulose Tape and Japanese paper masking tape for painting, while advancing marketing activities and product development tailored to regional demand. At our representative office in Düsseldorf, Germany, we are gathering information and conducting market research to expand our sales business and advance our growth strategy in Europe. Through our sales subsidiary in Bangkok, Thailand, we will also work to expand sales of the CareleavesTM series in the ASEAN region, where significantly greater demand is expected.」

「Through NICHIBAN (THAILAND) CO., LTD., our sales subsidiary in Bangkok, Thailand, we will work to expand sales of the CareleavesTM series of high-performance wound dressings in the ASEAN region, where significantly greater demand is expected.」

「In our overseas business, we are focusing on Asia and Europe and advancing the development of sales channels, marketing activities, and products tailored to regional demand for medical business products, including the high-performance wound dressing CareleavesTM and the SesabrickTM series of hemostatic products, as well as tape business products such as PanfixTM Cellulose Tape and Japanese paper masking tape for painting.」

「In overseas markets, to advance the expansion and growth strategy of our sales business in Europe, we opened a representative office in Düsseldorf, Germany, in January 2019 and are gathering information and conducting market research.」

「In Europe as well, we are preparing to open a base for conducting marketing research and exploring sales channels.」

「In our overseas business, we are focusing on Asia and Europe, building sales channels, conducting marketing activities, and developing products tailored to regional demand for medical business products, including the high-performance wound dressing CareleavesTM and the SesabrickTM series of hemostatic products, as well as tape business products such as PanfixTM Cellulose Tape and Japanese paper masking tape for painting. We are also expanding locally focused sales activities through NICHIBAN (THAILAND) CO., LTD., a sales subsidiary established in Bangkok, Thailand, during the previous consolidated fiscal year, with the aim of increasing sales.」

「In our overseas business, we are focusing on Asia and Europe, building sales channels, conducting marketing activities, and developing products tailored to regional demand for medical business products, including the high-performance wound dressing CareleavesTM and the SesabrickTM series of hemostatic products, as well as tape business products such as PanfixTM Cellulose Tape and Japanese paper masking tape for painting. We are also expanding locally focused sales activities through NICHIBAN (THAILAND) CO., LTD., a sales subsidiary established in Bangkok, Thailand, during the previous consolidated fiscal year, with the aim of increasing sales.」

「In overseas markets, we will further expand locally focused sales activities at NICHIBAN (THAILAND) CO., LTD., a sales subsidiary established in Bangkok, Thailand, in July 2017, and increase sales. We have also established distribution channels with local business partners and will seek to expand sales of the high-performance wound dressing CareleavesTM in Asia, where significantly greater demand is expected. In addition, we will expand sales in Asia of PanfixTM Cellulose Tape, manufactured by our affiliate UNION THAI-NICHIBAN CO., LTD., by continuing sales activities with existing customers and developing new customers.」

「In our overseas business, we are continuing marketing activities in each country, advancing product development to meet overseas demand, and developing sales channels through NICHIBAN (THAILAND) CO., LTD., a sales subsidiary established in Bangkok, Thailand, during the second quarter of the current consolidated fiscal period. We have also begun sales activities for medical business products, including the high-performance wound dressing CareleavesTM and the SesabrickTM series of hemostatic products, as well as tape business products such as PanfixTM Cellulose Tape and Japanese paper masking tape for painting.」

「In the overseas business, the Company continues marketing activities in each country and is developing products to meet overseas demand. It is also building sales channels for Medical Business products, such as the high-performance first-aid adhesive bandage Careleaves™ and the Sesabric™ series of hemostatic products, and Tape Business products, such as Panfix™ Cellulose Tape and Japanese paper masking tape for painting.」

「By establishing a sales base in Thailand, the Company aims to strengthen its business operations and expand sales in Southeast and South Asian countries, which are important markets, through locally focused sales activities.」

「In the overseas business, the Company continues marketing activities in each country and is developing products to meet overseas demand. It is also exhibiting at trade fairs and business meetings, while building sales channels and expanding sales for Medical Business products, such as the high-performance first-aid adhesive bandage Careleaves™ and Tape Business products, such as Japanese paper masking tape for painting.」

「In the overseas business, the Company continues marketing activities in each country and is developing products to meet overseas demand. It is also exhibiting at trade fairs and business meetings, while building sales channels and expanding sales for Medical Business products, including the high-performance first-aid adhesive bandage Careleaves™ product range, and Tape Business products, such as Japanese paper masking tape for painting.」

「In the overseas business, the Company continues marketing activities in each country, centered on its representative office in Bangkok, Thailand, and is developing products to meet overseas demand. It is also exhibiting Medical Business products, such as the high-performance first-aid adhesive bandage Careleaves™ series, and Tape Business products, such as Japanese paper masking tape for painting, at trade fairs and business meetings in various countries, while building sales channels and expanding sales.」

「3) Development of new overseas markets *Active expansion of Medical products targeting Asia and Europe」